个性化文献订阅>期刊> Current Pharmaceutical Design
 

P-Selectin Antagonism in Inflammatory Disease

  作者 Woollard, KJ; Chin-Dusting, J  
  选自 期刊  Current Pharmaceutical Design;  卷期  2010年16-37;  页码  4113-4118  
  关联知识点  
 

[摘要]Inflammation plays a fundamental role in many chronic diseases, including atherosclerosis associated cardiovascular disease. Adhesion of immune cells plays a critical role in the inflammatory response and indeed the pathophysiology of inflammatory related diseases. P-selectin is an inflammatory adhesion molecule, enabling the recruitment of leukocytes to the endothelium and to activated platelets involved in the growing thrombus. P-selectin is critical in the progression of atherosclerosis as evidenced by knockout animal models where P-selectin knockout mice crossed with apoE deficient mice exhibit significantly reduced atherosclerosis and leukocyte recruitment in the plaque. A soluble form of P-selectin also exists, which may have pro-atherogenic and pro-thrombotic effects. Thus targeting of P-selectin remains a strong clinical candidate for developing novel therapeutic strategies in inflammatory diseases. This review will discuss the role of P-selectin and describe the function of P-selectin antagonists as clinical targets.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内